Survey on recent developments in automatic detection of diabetic retinopathy

J Fr Ophtalmol. 2021 Mar;44(3):420-440. doi: 10.1016/j.jfo.2020.08.009. Epub 2021 Jan 30.

Abstract

Diabetic retinopathy (DR) is a disease facilitated by the rapid spread of diabetes worldwide. DR can blind diabetic individuals. Early detection of DR is essential to restoring vision and providing timely treatment. DR can be detected manually by an ophthalmologist, examining the retinal and fundus images to analyze the macula, morphological changes in blood vessels, hemorrhage, exudates, and/or microaneurysms. This is a time consuming, costly, and challenging task. An automated system can easily perform this function by using artificial intelligence, especially in screening for early DR. Recently, much state-of-the-art research relevant to the identification of DR has been reported. This article describes the current methods of detecting non-proliferative diabetic retinopathy, exudates, hemorrhage, and microaneurysms. In addition, the authors point out future directions in overcoming current challenges in the field of DR research.

Keywords: Artificial intelligence; Deep learning; Diabetic retinopathy; Fundus images; Images du fond d’œil; Intelligence artificielle; Machine learning; Ophtalmologie; Ophthalmology; Rétinopathie diabétique.

Publication types

  • Review

MeSH terms

  • Artificial Intelligence
  • Diabetes Mellitus*
  • Diabetic Retinopathy* / diagnosis
  • Fundus Oculi
  • Humans
  • Microaneurysm* / diagnosis
  • Retina